NASDAQ: MPLT
Maplight Therapeutics Inc Earnings Dates, Reports, Calls

Maplight Therapeutics earnings were N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest MPLT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$29.4M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MPLT reported annual earnings of -$77.6M, with 39.3% growth. The next MPLT earnings date is Mar 12, 2026.

MPLT earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

MPLT Return on Equity

Insufficient data to display

MPLT Return on Assets

Insufficient data to display

Be the first to know when MPLT announces earnings.

MPLT Return on Capital Employed

Current Company
0%
Current Industry
-3.5%

MPLT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MPLTN/AN/AN/AN/A
ABUS-$41.48M-$42.28MN/A-$0.23
KALVN/AN/AN/AN/A
JANX-$99.82M-$101.90MN/A-$1.67
GYRE$13.23M$6.65M-99.59%$0.07

MPLT earnings dates

Next earnings date
Mar 12, 2026

Maplight Therapeutics Earnings Reports & History FAQ

What were Maplight Therapeutics's earnings last quarter?

Maplight Therapeutics (NASDAQ: MPLT) reported Q3 2025 earnings per share (EPS) of -$37.18, up 48.25% year over year. Total MPLT earnings for the quarter were -$29.42 million. In the same quarter last year, Maplight Therapeutics's earnings per share (EPS) was -$25.08.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.

When does Maplight Therapeutics report earnings?

The next MPLT earnings call is Invalid Date. Add MPLT to your watchlist to be reminded of Maplight Therapeutics's next earnings date.

Is Maplight Therapeutics profitable or losing money?

As of the last Maplight Therapeutics earnings report, Maplight Therapeutics is currently losing money. Maplight Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was N/A, a N/A decrease year over year.

What was MPLT's earnings growth in the past year?

As of Maplight Therapeutics's earnings date in Q1 2026, Maplight Therapeutics's earnings has grown year over year. MPLT earnings in the past year totalled N/A.

What are Maplight Therapeutics's earnings expectations?

The current EPS estimate for Maplight Therapeutics's earnings report in Invalid Date is -$1.25.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.